ELDISINE

This brand name is authorized in Austria, France, Italy, United Kingdom

Active ingredients

The drug ELDISINE contains one active pharmaceutical ingredient (API):

1
UNII CPH2U7DNDY - VINDESINE SULFATE
 

Vindesine is an antineoplastic agent derived from vinblastine, like the other vinca alkaloids it causes mitotic arrest in metaphase by binding to microtubular protein.
 
Read more about Vindesine

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ELDISINE Powder for solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L01CA03 Vindesine L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CA Vinca alkaloids and analogues
Discover more medicines within L01CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
FR Base de données publique des médicaments 61886269
GB Medicines & Healthcare Products Regulatory Agency 75011
IT Agenzia del Farmaco 025289024

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈